Team
Pipeline
Ophthalmology
Metabolic Disease
Neurology
Ophthalmology
Metabolic Disease
Neurology
Platform
Manufacturing
Product Design
Research & Development
Manufacturing
Product Design
Research & Development
Newsroom
Careers
Newsroom
Search
Search
January 26, 2022
Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases
: Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases
July 28, 2021
Kriya Therapeutics Completes Renovation of its Facility for Scalable Gene Therapy Manufacturing
: Kriya Therapeutics Completes Renovation of its Facility for Scalable Gene Therapy Manufacturing
July 14, 2021
Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
: Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
August 4, 2020
Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases
: Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases
May 12, 2020
Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases
: Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases
Previous
1
2
3
